Loading...
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
Support for the N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis of schizophrenia has led to increasing focus on restoring proper glutamatergic signaling as an approach for treatment of this devastating disease. The ability of metabotropic glutamate (mGlu) receptors to modulate glutamat...
Na minha lista:
| Udgivet i: | Mol Brain |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5405554/ https://ncbi.nlm.nih.gov/pubmed/28446243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13041-017-0293-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|